Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Baldoncini

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Diabetologia|January 1, 1997
Elevated plasma endothelin-1 levels as an additional risk factor in non-obese essential hypertensive patients with metabolic abnormalitiesC Ferri, C Bellini, G Desideri, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|February 1, 1996
Plasma and urinary digitalis-like substance levels during atrial natriuretic peptide infusion in essential hypertensive patientsR Baldoncini, C Ferri, C Bellini, et al.
Nephron|January 1, 1997
Elevated albumin excretion in nonmodulating essential hypertensive patientsR Baldoncini, C Bellini, G Desideri, et al.
Circulation|December 1, 1994
Abnormal atrial natriuretic peptide and renal responses to saline infusion in nonmodulating essential hypertensive patientsC Ferri, C Bellini, S Coassin, et al.
Clinical Science (London, England : 1979)|February 25, 1999
Angiotensin II increases the release of endothelin-1 from human cultured endothelial cells but does not regulate its circulating levelsC Ferri, G Desideri, R Baldoncini, et al.
Kidney International|October 3, 1999
High plasma renin activity is combined with elevated urinary albumin excretion in essential hypertensive patientsR Baldoncini, G Desideri, C Bellini, et al.
American Journal of Nephrology|January 1, 1995
Hormonal and renal responses to atrial natriuretic peptide infusion in low-renin hypertensionC Ferri, R Baldoncini, C Bellini, et al.
Diabetes|May 6, 1998
Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalitiesC Ferri, G Desideri, R Baldoncini, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Circulating endothelin-1 levels in obese patients with the metabolic syndromeC Ferri, C Bellini, G Desideri, et al.
European Journal of Clinical Investigation|June 1, 1997
Plasma endothelin-1 levels during transient acute myocardial ischaemia in men: effects of coronary revascularizationC Ferri, P De Marzio, G Desideri, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Diabetologia|January 1, 1997
Elevated plasma endothelin-1 levels as an additional risk factor in non-obese essential hypertensive patients with metabolic abnormalitiesC Ferri, C Bellini, G Desideri, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|February 1, 1996
Plasma and urinary digitalis-like substance levels during atrial natriuretic peptide infusion in essential hypertensive patientsR Baldoncini, C Ferri, C Bellini, et al.
Nephron|January 1, 1997
Elevated albumin excretion in nonmodulating essential hypertensive patientsR Baldoncini, C Bellini, G Desideri, et al.
Circulation|December 1, 1994
Abnormal atrial natriuretic peptide and renal responses to saline infusion in nonmodulating essential hypertensive patientsC Ferri, C Bellini, S Coassin, et al.
Clinical Science (London, England : 1979)|February 25, 1999
Angiotensin II increases the release of endothelin-1 from human cultured endothelial cells but does not regulate its circulating levelsC Ferri, G Desideri, R Baldoncini, et al.
Kidney International|October 3, 1999
High plasma renin activity is combined with elevated urinary albumin excretion in essential hypertensive patientsR Baldoncini, G Desideri, C Bellini, et al.
American Journal of Nephrology|January 1, 1995
Hormonal and renal responses to atrial natriuretic peptide infusion in low-renin hypertensionC Ferri, R Baldoncini, C Bellini, et al.
Diabetes|May 6, 1998
Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalitiesC Ferri, G Desideri, R Baldoncini, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Circulating endothelin-1 levels in obese patients with the metabolic syndromeC Ferri, C Bellini, G Desideri, et al.
European Journal of Clinical Investigation|June 1, 1997
Plasma endothelin-1 levels during transient acute myocardial ischaemia in men: effects of coronary revascularizationC Ferri, P De Marzio, G Desideri, et al.
Pageof 2